Multicentre, controlled, prospective, randomized, open-label clinical trial to compare enteric-coated mycophenolate sodium (EC-MPS) plus reduced dose cyclosporine microemulsion (CsA-ME) vs EC-MPS plus standard dose CsA-ME in elderly de novo renal transplant recipients treated with basiliximab and short-term steroids.
Phase of Trial: Phase III
Latest Information Update: 28 Jan 2011
At a glance
- Drugs Mycophenolate sodium (Primary) ; Basiliximab; Ciclosporin; Corticosteroids
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 17 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History